A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/28/2006	US7141237 Pharmaceutical foam
11/28/2006	US7141236 In situ bioavailability; lipid microstructure
11/28/2006	US7141235 System uses a phospholipid in conjunction with a second surfactant of higher water solubility as a stabilizing surfactant to improve gas entrapment
11/28/2006	CA2489809C Active substance controlled release devices and process for producing the same
11/28/2006	CA2301185C Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
11/28/2006	CA2216320C Stable emulsions and dry powders of mixtures of fat-soluble vitamins, their preparation and use
11/28/2006	CA2150945C Ibuprofen-containing effervescent pharmaceutical composition and process for preparing the same
11/23/2006	WO2008030209A2 Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
11/23/2006	WO2006125132A2 Aerosolized fluoroquinolones and uses thereof
11/23/2006	WO2006125074A1 Drug delivery formulations for targeted delivery
11/23/2006	WO2006124923A1 Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
11/23/2006	WO2006124915A1 Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents
11/23/2006	WO2006124898A1 Morphine sulfate formulations
11/23/2006	WO2006124890A1 Morphine sulphate formulations
11/23/2006	WO2006124749A2 Multilayer drug delivery system with barrier against antagonist exposure
11/23/2006	WO2006124585A2 Multilayer drug system for the delivery of galantamine
11/23/2006	WO2006124584A2 Multilayer drug delivery system with barrier against reservoir material flow
11/23/2006	WO2006124421A1 Extended release tablet
11/23/2006	WO2006124224A1 Oil encapsulation
11/23/2006	WO2006124161A1 Sustained release l-arginine formulations and methods of manufacture and use
11/23/2006	WO2006124056A2 Melanin nanoshells for protection against radiation and electronic pulses
11/23/2006	WO2006124047A2 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
11/23/2006	WO2006124043A2 Personal care and surface cleaning article
11/23/2006	WO2006123766A1 Film coated preparation containing dextrose
11/23/2006	WO2006123765A1 Film coated preparation
11/23/2006	WO2006123678A1 Stable tablet containing droxidopa
11/23/2006	WO2006123676A1 Prophylactic or therapeutic agent for corneal and conjunctival disorder
11/23/2006	WO2006123364A2 Oral drug delivery system providing a coating comprising both a cellulose and a methacrylic acid derivative
11/23/2006	WO2006123361A2 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof
11/23/2006	WO2006123360A2 Microspheres containing octreotide acetate
11/23/2006	WO2006123359A2 A process of making microspheres
11/23/2006	WO2006123357A2 Oral controlled release composition containing levetiracetam
11/23/2006	WO2006123354A2 Oral pharmaceutical composition
11/23/2006	WO2006123324A1 Topical compositions
11/23/2006	WO2006123299A2 Methods for fabricating micro-electro-mechanical devices
11/23/2006	WO2006123243A2 Pharmaceutical dosage forms comprising escitalopram in form of granules
11/23/2006	WO2006123223A1 Pharmaceutical compostions comprising an amorphous form of a vegf-r inhibitor
11/23/2006	WO2006123213A1 Modified release formulations of gliclazide
11/23/2006	WO2006123073A1 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof
11/23/2006	WO2006122973A1 Composition for treatment of a detached retina and method of production thereof
11/23/2006	WO2006122925A2 Oral medicament based on a proton pump inhibitors
11/23/2006	WO2006122914A2 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous
11/23/2006	WO2006122835A1 Colonic delivery of adsorbents
11/23/2006	WO2006122828A2 Optimized injection formulation for rna
11/23/2006	WO2006122790A1 Inhalator capsules
11/23/2006	WO2006122638A1 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
11/23/2006	WO2006122543A1 Micronized mineral materials and their production
11/23/2006	WO2006122485A1 A pharmaceutical composition for treating diabetes and process thereof
11/23/2006	WO2006122472A1 Antithyroid ointment for external use and the preparation thereof
11/23/2006	WO2006122462A1 A oral preparation comprising dyclonine hydrochloride
11/23/2006	WO2006122454A1 A pharmaceutical composition for treating diabetes and preparation method thereof
11/23/2006	WO2006122414A1 Depot for sustained and controlled delivery of methotrexate
11/23/2006	WO2006122345A1 Method and composition for use in preparation of a patient for surgery
11/23/2006	WO2006105155A3 Administration of glutathione (reduced) via intravenous or encapsulated in liposome for treatment of tnf-alpha effects and elu-like viral symptoms
11/23/2006	WO2006089215A3 Pharmaceutical compositions and methods
11/23/2006	WO2006086107A3 Methods and compositions for minimizing accrual of inhalable insulin in the lungs
11/23/2006	WO2006085101A3 Pharmaceutical compositions useful in the transmucosal administration of drugs
11/23/2006	WO2006084164A3 Gastric retention and controlled release delivery system
11/23/2006	WO2006083950A3 Method for reducing the level of peroxides in bopcompatible polymer preparations
11/23/2006	WO2006081518A3 Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
11/23/2006	WO2006078640A3 Alterations utilizing nanoparticles
11/23/2006	WO2006077398A3 Microcapsule
11/23/2006	WO2006077394A3 Formulation
11/23/2006	WO2006060051A3 Enzyme chimeras and methods of their use for the treatment of infection by bacillus anthracis
11/23/2006	WO2006047689A3 Dosage forms having a microreliefed surface and methods and apparatus for their production
11/23/2006	WO2006047688A3 Dosage forms having a microreliefed surface and methods and apparatus for their production
11/23/2006	WO2006044861A3 Pharmaceutical mixture evaluation
11/23/2006	WO2006016097A3 Vector comprising polymer modified sirna liposomes
11/23/2006	WO2006007136B1 Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease
11/23/2006	WO2005120392A3 Prosthetic device having drug delivery properties
11/23/2006	WO2005110473A3 Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
11/23/2006	WO2005097066A3 Controlled delivery of therapeutic agents from medical articles
11/23/2006	WO2005089797A3 Support system in the form of protein-based nanoparticles for the cell-specific enrichment of pharmaceutically active substances
11/23/2006	WO2005077450A3 Intravascular delivery system for therapeutic agents
11/23/2006	WO2005000224A3 Novel dermatological composition
11/23/2006	US20060264913 Implantable flow regulator with failsafe mode and reserve drug supply
11/23/2006	US20060264912 Medical devices for treating urological and uterine conditions
11/23/2006	US20060264911 Squeeze-actuated catheter connector and method
11/23/2006	US20060264829 Disposable fluid container with integrated pump motive assembly
11/23/2006	US20060264814 Locking catheter connector and method
11/23/2006	US20060264516 Use of low molecular weight amino alcohols in ophthalmic compositions
11/23/2006	US20060264510 Antiviral methods and compositions
11/23/2006	US20060264506 Meldonium salts, method of their preparation and pharmaceutical composition on their basis
11/23/2006	US20060264505 Dermatological compositions
11/23/2006	US20060264502 Agent for treatment of cisplatin-resistant cancer
11/23/2006	US20060264469 Pharmaceutical composition for oral administration of a pyrazole-3-carboxamide derivative
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060263801 Methods of high-throughput screening for internalizing antibodies
11/23/2006	US20060263772 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
11/23/2006	US20060263451 For administering an extract of Costus pictus to a mammal
11/23/2006	US20060263447 Treating pulmonary disorders with gaseous agent causing repletion of GSNO
11/23/2006	US20060263439 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
11/23/2006	US20060263438 Gelled oil particles for targeting sebaceous glands and/or hair follicles
11/23/2006	US20060263437 Pharmaceutical microspheres containing valproic acid for oral administration
11/23/2006	US20060263436 once daily dosage form of itraconazole independent of food intake; melt-extruding a mixture comprising itraconazole and an appropriate water-soluble polymer and subsequently milling
11/23/2006	US20060263435 nucleic acid such as siRNAs; carrier includes a cyclodextrin polymer; treatment of cell proliferative disorders, such as cancer or pathogen infections
11/23/2006	US20060263434 Combinations and modes of administration of therapeutic agents and combination therapy
11/23/2006	US20060263433 Suspension formulation of interferon
11/23/2006	US20060263432 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof
11/23/2006	US20060263431 Opioid Sustained Release Formulation

1 ... 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 ... 2991